Feasibility and Efficacy of Salvage Allogeneic Stem Cell Transplantation in AML Patients Relapsing after Autologous Stem Cell Transplantation

Investigators suggested that almost 80% of acute myeloid leukemia patients could undergo salvage therapy following relapse after front-line high-dose chemotherapy/autologous hematopoietic cell transplantation.